Orion Nutraceuticals Seeks Shareholder Approval to Delist from the CSE

(TheNewswire)

Vancouver, British Columbia – June26, 2025 – TheNewswire - Orion NutraceuticalsInc. , (CSE: ORI ) (the “ Company ” or“ Orion ”) announces thatit intends to seek shareholder approval to voluntarily delist itscommon shares from the Canadian Securities Exchange (the" CSE ") at its annual general and special meeting ofshareholders scheduled for July 4, 2025 (the “ AGSM ”).

The Company has determined that a voluntary delistingfrom the CSE (the " Delisting ") is in the best interests ofboth shareholders and the Company. This decisionhas been made in light of prolonged weak market conditions and formspart of the Company’s broader strategy to preserve its business andworking capital position.

The Company’s board of directors the (“ Board ”) hascarefully considered all available options to maintain and sustain theCompany’s operations. As part of this review, the Board identifiedthe ongoing cost burden of remaining a listed issuer as a significantfactor. After evaluating the cost-benefit implications, the Boardconcluded that proceeding with the Delisting represents a prudentcourse of action aimed at supporting the long-term interests of theCompany and its shareholders.

Despite the Delisting, the Company will continue to besubject to ongoing disclosure and other obligations as a reportingissuer under applicable securities legislation in Canada. The Companyis required to obtain the approval of its disinterested shareholdersto approve the Delisting of its common shares from the CSE. In seekingsuch disinterested shareholder approval, the Company shall exclude allvotes attached to the common shares held by the directors, officersand insiders of the Company, who collectively hold nil commonshares.

For further details regarding the AGSM, please refer tothe Company’s management information circular, available under itsprofile at www.sedarplus.ca .

About Orion NutraceuticalsInc.

Orion Nutraceuticals Inc. is actively evaluatingpotential investment and acquisition opportunities. Orion shares tradein Canada on the CSE under the symbol ORI.

ON BEHALF OF THE BOARD

Guy Bourgeois, Director
Tel: ( 604) 687-2038

The CSE hasneither approved nor disapproved the contents of this news release.Neither the CSE nor its Market Regulator (as that term is defined inthe policies of the CSE) accepts responsibility for the adequacy oraccuracy of this news release.

Forward-LookingStatements

This news release contains"forward-looking information" and "forward-lookingstatements" (collectively, “forward-looking statements”)within the meaning of applicable securities laws, including statementsregarding the Company’s intention to delist from CSE, theanticipated benefits of the Delisting, the Company’s ongoingobligations as a reporting issuer, and the potential impact onshareholders and trading liquidity. Forward-looking statements arebased on the opinions, assumptions and estimates of management as ofthe date they are made and are subject to various known and unknownrisks and uncertainties.

These risks include, but are notlimited to, changes in market conditions, regulatory developments, theCompany’s ability to maintain compliance with applicable laws, andother factors that may cause actual outcomes to differ materially fromthose expressed or implied by such forward-looking statements.

Readers are cautioned not to placeundue reliance on forward-looking statements. Except as required byapplicable law, the Company undertakes no obligation to update orrevise any forward-looking statements, whether as a result of newinformation, future events or otherwise.

Copyright (c) 2025 TheNewswire - All rights reserved.